European Journal of Biomedical and Pharmaceutical Sciences

A MIRACLE: PERINATAL OUTCOME OF NORMAL AN ALIVE FETUS WITH PLACENTAL MESENCHYMAL DYSPLASIA

Dr. Sharif Jamal Hamed Salha* and Dr. Madleen Jawad Sobhe Abu Aser

ABSTRACT

Objective: The purpose of this study was to look at the etiology, molecular pathology, gross and microscopic features, clinical presentation, consequences, ultrasound features and differential diagnosis of placental mesenchymal dysplasia Methodology: We examined PMD case from our institution and conducted a original research of the literature. Patient concerns: We report the case of a 20-year-old woman, Gravida 1, Para 0, that presented to the Jana IVF Centre for routine ultrasound in October 2019. She known as case of uncontrolled hypertension presented at 18 weeks of gestation for follow up. Diagnosis: Placental mesenchymal dysplasia associated with normal viable fetus, oligohydraminous, and hypertension. Intervention: A live female infant was delivered by emergency caesarean section. Outcomes: single alive female baby weights 2700 grams, no history of admission to neonatal ICU. Conclusion: Molar pregnancy and other placental vascular abnormalities are among the PMD differential diagnosis. Because PMD is linked to a poor pregnancy outcome, increased surveillance, including genetic testing, serial growth scans, and a third-trimester well-being assessment, should be explored. Because of the differences in management and results, PMD must be distinguished from prenatal trophoblastic illness.

Keywords: placental mesenchymal dysplasia, hypertension, molar pregnancy, oligohydraminous, intrauterine growth restriction, Beckwith–Wiedemann syndrome.